![](/img/cover-not-exists.png)
Eldelumab [anti-interferon-γ-inducible protein-10 antibody] Induction Therapy for Active Crohn’s Disease: a Randomised, Double-blind, Placebo-controlled Phase IIa Study
Sandborn, William J., Rutgeerts, Paul, Colombel, Jean-Frédéric, Ghosh, Subrata, Petryka, Robert, Sands, Bruce E., Mitra, Pranab, Luo, AllisonLanguage:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjx005
Date:
February, 2017
File:
PDF, 302 KB
english, 2017